LBC
DGX icon

Lowe Brockenbrough & Co’s Quest Diagnostics DGX Stock Holding History

Lowe Brockenbrough & Co’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.9M Sell
14,787
-455
-3% -$88.4K 0.14% 110
2025
Q4 		$2.64M Sell
15,242
-572
-4% -$104K 0.13% 113
2025
Q3 		$3.01M Sell
15,814
-341
-2% -$60.5K 0.16% 111
2025
Q2 		$2.9M Sell
16,155
-215
-1% -$37.3K 0.16% 114
2025
Q1 		$2.77M Sell
16,370
-669
-4% -$110K 0.18% 108
2024
Q4 		$2.57M Sell
17,039
-514
-3% -$79.9K 0.16% 115
2024
Q3 		$2.73M Sell
17,553
-637
-4% -$95.1K 0.17% 114
2024
Q2 		$2.49M Sell
18,190
-1,305
-7% -$179K 0.17% 112
2024
Q1 		$2.6M Sell
19,495
-1,593
-8% -$207K 0.18% 111
2023
Q4 		$2.91M Buy
21,088
+455
+2% +$59.8K 0.23% 102
2023
Q3 		$2.51M Sell
20,633
-395
-2% -$52.6K 0.2% 111
2023
Q2 		$2.96M Sell
21,028
-37
-0.2% -$5.1K 0.22% 100
2023
Q1 		$2.98M Sell
21,065
-17
-0.1% -$2.43K 0.24% 100
2022
Q4 		$3.3M Sell
21,082
-614
-3% -$88.2K 0.29% 87
2022
Q3 		$2.66M Buy
21,696
+198
+0.9% +$26.1K 0.26% 96
2022
Q2 		$2.86M Sell
21,498
-1,540
-7% -$210K 0.25% 97
2022
Q1 		$3.15M Sell
23,038
-1,215
-5% -$169K 0.23% 101
2021
Q4 		$4.2M Sell
24,253
-100
-0.4% -$15.2K 0.31% 82
2021
Q3 		$3.54M Buy
24,353
+217
+0.9% +$31.8K 0.28% 95
2021
Q2 		$3.19M Buy
24,136
+165
+0.7% +$21.6K 0.29% 86
2021
Q1 		$3.08M Sell
23,971
-130
-0.5% -$16K 0.3% 85
2020
Q4 		$2.87M Sell
24,101
-565
-2% -$68.9K 0.31% 85
2020
Q3 		$2.82M Sell
24,666
-305
-1% -$36K 0.35% 80
2020
Q2 		$2.85M Sell
24,971
-1,599
-6% -$170K 0.38% 73
2020
Q1 		$2.13M Sell
26,570
-411
-2% -$42.5K 0.35% 82
2019
Q4 		$2.88M Sell
26,981
-80
-0.3% -$8.34K 0.36% 80
2019
Q3 		$2.9M Sell
27,061
-311
-1% -$31.9K 0.39% 79
2019
Q2 		$2.79M Sell
27,372
-27
-0.1% -$2.6K 0.38% 79
2019
Q1 		$2.46M Buy
27,399
+152
+0.6% +$13.2K 0.34% 84
2018
Q4 		$2.27M Buy
27,247
+337
+1% +$31.6K 0.37% 80
2018
Q3 		$2.9M Sell
26,910
-150
-0.6% -$16.5K 0.41% 72
2018
Q2 		$2.98M Sell
27,060
-840
-3% -$87.5K 0.44% 72
2018
Q1 		$2.8M Buy
27,900
+70
+0.3% +$7.17K 0.41% 75
2017
Q4 		$2.74M Sell
27,830
-65
-0.2% -$6.16K 0.39% 76
2017
Q3 		$2.61M Sell
27,895
-525
-2% -$55.7K 0.4% 76
2017
Q2 		$3.16M Sell
28,420
-220
-0.8% -$23.3K 0.5% 65
2017
Q1 		$2.81M Sell
28,640
-460
-2% -$43.9K 0.45% 72
2016
Q4 		$2.67M Sell
29,100
-140
-0.5% -$12.1K 0.45% 68
2016
Q3 		$2.48M Sell
29,240
-135
-0.5% -$11.3K 0.43% 75
2016
Q2 		$2.39M Sell
29,375
-35
-0.1% -$2.67K 0.42% 73
2016
Q1 		$2.1M Buy
29,410
+800
+3% +$53.7K 0.36% 77
2015
Q4 		$2.04M Sell
28,610
-400
-1% -$26.9K 0.35% 84
2015
Q3 		$1.78M Buy
29,010
+340
+1% +$23.8K 0.31% 88
2015
Q2 		$2.08M Sell
28,670
-217
-0.8% -$16K 0.33% 85
2015
Q1 		$2.22M Sell
28,887
-83
-0.3% -$5.94K 0.35% 85
2014
Q4 		$1.94M Sell
28,970
-520
-2% -$32.8K 0.31% 86
2014
Q3 		$1.79M Sell
29,490
-1,275
-4% -$78.6K 0.29% 88
2014
Q2 		$1.81M Sell
30,765
-150
-0.5% -$8.78K 0.29% 87
2014
Q1 		$1.79M Buy
30,915
+885
+3% +$47.4K 0.3% 86
2013
Q4 		$1.61M Buy
30,030
+10,315
+52% +$612K 0.27% 86
2013
Q3 		$1.22M Buy
19,715
+75
+0.4% +$4.49K 0.22% 97
2013
Q2 		$1.19M Buy
+19,640
New +$1.17M 0.22% 97

Other funds holding DGX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return

Lowe Brockenbrough & Co's DGX Position: Q1 2026 in Review

Lowe Brockenbrough & Co reduced its Quest Diagnostics (DGX) stake by 3% in Q1 2026, selling an estimated $88.4K and leaving 14,787 shares worth $2.9M. The position accounts for 0.14% of the portfolio, ranked #110.

Lowe Brockenbrough & Co first reported a position in DGX in Q2 2013 and has held it in 52 quarters since. The position peaked at $4.2M in Q4 2021. 1,063 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

  • Lowe Brockenbrough & Co held 14,787 shares of Quest Diagnostics worth $2.9M as of Q1 2026.
  • Lowe Brockenbrough & Co sold 455 Quest Diagnostics shares in Q1 2026, an estimated $88.4K.
  • Quest Diagnostics made up 0.14% of Lowe Brockenbrough & Co's portfolio in Q1 2026, its #110 holding.
  • Lowe Brockenbrough & Co first reported a position in Quest Diagnostics in Q2 2013 and has held it in 52 quarters since.
  • Lowe Brockenbrough & Co's Quest Diagnostics position peaked at $4.2M in Q4 2021.
  • 1,063 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on Lowe Brockenbrough & Co's 13F filing for Q1 2026, filed 7 May 2026.